A Study of LY3337641 in Healthy Participants

NCT03099148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Reference Formulation (R)
DRUG: LY3337641 (T1)
DRUG: LY3337641 (T2)

Sponsor

Eli Lilly and Company